Concepedia

Reduction in CMR Derived Extracellular Volume With Patisiran Indicates Cardiac Amyloid Regression

Marianna Fontana, Ana Martinez–Naharro, Liza Chacko, Dorota Rowczenio, Janet A. Gilbertson, Carol Whelan, Svetla Strehina, Thirusha Lane, James Moon, David F. Hutt,

JACC. Cardiovascular imaging · 2020 · 195 citations · 22 references

DOI

Concepts

References

22

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

David Adams, Alejandra González‐Duarte, William O’Riordan et al. · New England Journal of Medicine · 2018 · 2.9K citations · Full text

, , +14

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

Jeffrey H. Schwartz, Balarama Gundapaneni, Perry Elliott et al. · New England Journal of Medicine · 2018 · 2.7K citations · Full text

, , +13

Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis

Julian D. Gillmore, Rodney H. Falk, Giampaolo Merlini et al. · Circulation · 2016 · 2K citations · Full text

, , +14

Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis

Merrill D. Benson, Márcia Waddington‐Cruz, John L. Berk et al. · New England Journal of Medicine · 2018 · 1.4K citations · Full text

, , +16

Natural History and Outcome in Systemic AA Amyloidosis

New England Journal of Medicine · 2007 · 878 citations · Full text

, , +13